These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

742 related items for PubMed ID: 3023423

  • 1. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B, Deuss U, Kaulen D, Leonhardt U, Kallabis D, Hamel E, Winkelmann W.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [Abstract] [Full Text] [Related]

  • 2. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 3. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B, Winkelmann W, Hipp FX, Kaulen D, Mies R.
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [Abstract] [Full Text] [Related]

  • 4. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H, Tamura T.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [Abstract] [Full Text] [Related]

  • 5. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK, Cutler GB, Oldfield EH, Loriaux DL, Chrousos GP.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [Abstract] [Full Text] [Related]

  • 6. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 7. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
    Arvat E, Giordano R, Ramunni J, Arnaldi G, Colao A, Deghenghi R, Lombardi G, Mantero F, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
    [Abstract] [Full Text] [Related]

  • 8. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y, Niinomi M, Takatsuki K, Oiso Y, Tomita A.
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [Abstract] [Full Text] [Related]

  • 9. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [Abstract] [Full Text] [Related]

  • 10. Effects of the combined administration of hexarelin, a synthetic peptidyl GH secretagogue, and hCRH on ACTH, cortisol and GH secretion in patients with Cushing's disease.
    Arvat E, Ramunni J, Giordano R, Maccagno B, Broglio F, Benso A, Deghenghi R, Ghigo E.
    J Endocrinol Invest; 1999 Jan; 22(1):23-8. PubMed ID: 10090133
    [Abstract] [Full Text] [Related]

  • 11. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 12. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.
    Arnaldi G, Tirabassi G, Papa R, Furlani G, Trementino L, Cardinaletti M, Faloia E, Boscaro M.
    Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661
    [Abstract] [Full Text] [Related]

  • 13. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT, Luria M.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]

  • 15. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL.
    N Engl J Med; 1984 Mar 08; 310(10):622-6. PubMed ID: 6319991
    [Abstract] [Full Text] [Related]

  • 16. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF, Hermus AR, Smals AG, Bartelink AK, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1983 Sep 08; 57(3):513-6. PubMed ID: 6308029
    [Abstract] [Full Text] [Related]

  • 17. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN.
    J Clin Endocrinol Metab; 1996 Aug 08; 81(8):2934-41. PubMed ID: 8768855
    [Abstract] [Full Text] [Related]

  • 18. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2002 Apr 08; 87(4):1640-5. PubMed ID: 11932295
    [Abstract] [Full Text] [Related]

  • 19. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar 08; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1995 Feb 08; 80(2):412-7. PubMed ID: 7852498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.